Theriva Biologics
TOVX
TOVX
70 hedge funds and large institutions have $34M invested in Theriva Biologics in 2016 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 21 increasing their positions, 9 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0% less ownership
Funds ownership: 0% → 0% (-0%)
44% less capital invested
Capital invested by funds: $60.8M → $34M (-$26.8M)
Holders
70
Holding in Top 10
2
Calls
$7.97M
Puts
–
Top Buyers
| 1 | +$3.5M | |
| 2 | +$2.31M | |
| 3 | +$767K | |
| 4 |
UOC
UBS O'Connor
Chicago,
Illinois
|
+$763K |
| 5 |
Millennium Management
New York
|
+$576K |
Top Sellers
| 1 | -$1.29M | |
| 2 | -$742K | |
| 3 | -$267K | |
| 4 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
-$131K |
| 5 |
RCP
Rothschild Capital Partners
New York
|
-$52K |